<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">

CU Cancer Center News and Stories


Patient Care    Lung Cancer    Oncology

‘A Way of Embodying Hope’: 5-Year Lung Cancer Survivors Celebrate

Two years after her lung cancer diagnosis in 2019, Dan Wu first came to D. Ross Camidge, MD, PhD, at the University of Colorado Cancer Center for a second opinion.

 “Dr. Camidge saved my life,” Wu said.

Author Mark Harden | Publish Date May 13, 2024
Full Story

Patient Care    Brain and Spinal Cancer    Oncology    Radiation

Brain Cancer Patient Recruits the CU Cancer Center for the Fight of His Life

Alex Cooper relishes a challenge. Armed with a New Yorker’s moxie, an entrepreneur’s savvy, and an athlete’s determination, he has launched startups, has competed in Ironman triathlons, and offers motivational messages in blogs, videos, and social media posts as the “Iron CEO.”

Author Mark Harden | Publish Date December 04, 2023
Full Story

Head and Neck Cancer    Cancer    Oncology    Immunotherapy

Selective Nodal Radiation May Be a More Effective Approach in Cancer Treatment

A promising new study released by the University of Colorado Cancer Center suggests that recurrence of certain cancers can be significantly decreased by irradiating only a select set of lymph nodes near a tumor rather than all of them.

Author Laura Kelley | Publish Date November 16, 2022
Full Story

Research    Faculty    Magazine    Oncology

Wells Messersmith, MD, Named CMO of Oncology Services at UCHealth

University of Colorado (CU) Cancer Center leader Wells Messersmith, MD, has been named chief medical officer of oncology services at UCHealth. In this new role, Messersmith will oversee cancer care at all UCHealth locations with a focus on expanding advanced treatments and the clinical trials UCHealth offers in partnership with the CU Cancer Center.

Author Cancer Center | Publish Date January 27, 2022
Full Story

Research    Oncology

Thousands of Coloradans contributing to cancer research at CU Cancer Center

When it comes to cancer research the more data, the better. That is the premise behind the Oncology Research Information Exchange Network (ORIEN). The research initiative brings together 19 accomplished cancer centers to accelerate the progress of cancer research and improve clinical care.

Author Cancer Center | Publish Date March 12, 2019
Full Story

Community    Faculty    Oncology

Molecular and Cellular Oncology Retreat 2019: Brrrrr!

In the field of Molecular and Cellular Oncology (MCO), cells often arrive frozen to the lab and must be thawed quickly by diluting with culture medium. And so it’s fitting that, on a macro level, molecular oncology researchers themselves arrived frozen to the 2019 MCO Retreat, held Monday at 9:00am and 4 degrees Fahrenheit on the CU Boulder campus, where they were immediately thawed with coffee.

Author Garth Sundem | Publish Date March 05, 2019
Full Story

CU Cancer Center In the News

News Medical

Study shows effectiveness of treating pancreatic cancer patients with chemotherapy before surgery

news outletNews Medical
Publish DateJune 19, 2024

A new study led by University of Colorado Cancer Center member Marco Del Chiaro, MD, PhD, reveals that nearly 5% of pancreatic adenocarcinoma patients achieved a pathological complete response (pCR) after pre-surgical chemotherapy or chemoradiotherapy. This significant finding indicates that patients with pCR have a 63% five-year survival rate, compared to 30% for those without pCR, suggesting the potential for tailored treatments to improve outcomes.

Full Story
Cancer Network

Liso-cel May Show Benefit in Earlier Therapy Lines for Lymphoma Subgroups

news outletCancer Network
Publish DateJune 14, 2024

In a conversation at the 2024 European Hematology Association Congress, CU Cancer Center member Manali Kamdar, MD, discussed potential future research on lisocabtagene maraleucel (liso-cel; Breyanzi) for mantle cell lymphoma (MCL) and other lymphoma subgroups. She highlighted findings from the phase 1 TRANSCEND NHL 001 trial, noting improved efficacy and safety in patients with fewer prior therapies and non-refractory disease, suggesting liso-cel's utility in earlier treatment lines and specific lymphoma subgroups.

Full Story
Cancer Health

2024 Cancer Health 25: People Who Power Clinical Trials

news outletCancer Health
Publish DateJune 11, 2024

This year's Cancer Health 25 highlights the transformative power and promise of clinical trials. University of Colorado Cancer Center member Jessica McDermott, MD, MSCS, is leading clinical trials at both the CU Cancer Center and the Rocky Mountain Regional Veterans Affairs Medical Center. Additionally, she serves as the CU Cancer Center's deputy associate director for diversity and inclusion in clinical research.

Full Story
Cancer Network

Learning to “Aim High” Within Male-Dominated Fields in Public Health

news outletCancer Network
Publish DateJune 10, 2024

Cathy Bradley, PhD, deputy director of the University of Colorado Cancer Center and dean of the Colorado School of Public Health, is a trailblazer in health economics. At a Breaking Barriers: Women in Oncology discussion, she shared insights on overcoming challenges as a woman in a male-dominated field and discussed her research on the impact of employment on cancer patients' health insurance decisions.

Full Story